Financials

  • Market Capitalization 77.51 M
  • Employee 14
  • Founded 2012
  • CEO N/A
  • Website www.cingulate.com
  • Headquarter Delaware, United States
  • FIGI BBG012G40MY2
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.98
Price to sales ratio
-10.12

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4055
TENX
Tenax Therapeutics, Inc. - Common Stock
2.13 USD-2.74%+25.29%-85.70%-71.79%79.71 M USD
4059
TELO
Telomir Pharmaceuticals, Inc. - Common Stock
1.14 USD-4.20%+0.88%-6.56%-12.31%78.40 M USD
4072
GANX
Gain Therapeutics, Inc. - Common Stock
1.77 USD-4.32%-11.94%+4.12%-7.81%77.25 M USD
4086
LONA
LeonaBio, Inc. - Common Stock
8.00 USD+1.39%+5.68%+11.11%+18.69%75.37 M USD

Frequently asked questions about Cingulate Inc. Common Stock

What is the Cingulate Inc. Common Stock stock price today?

The current price of Cingulate Inc. Common Stock (CING) is 5.33. Over the past 24 hours, the stock has changed by -2.02%. Follow the CING chart for real-time price dynamics.

What is the stock ticker of Cingulate Inc. Common Stock?

Cingulate Inc. Common Stock trades under the ticker CING. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Cingulate Inc. Common Stock stock going up?

CING has changed by -3.27% over the last week, +17.66% over the last month, and -13.47% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Cingulate Inc. Common Stock?

Cingulate Inc. Common Stock currently has a market capitalization of 77.51 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Cingulate Inc. Common Stock earnings last quarter?

Last quarter, Cingulate Inc. Common Stock reported earnings of -0.45 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Cingulate Inc. Common Stock revenue for the last quarter?

Cingulate Inc. Common Stock reported quarterly revenue of -290.63 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Cingulate Inc. Common Stock net income for the last quarter?

Cingulate Inc. Common Stock reported net income of -5.87 M for the last quarter. The previous quarter showed -9.31 M, which means net income changed by +36.96%.

How many employees does Cingulate Inc. Common Stock have?

As of the latest available data, Cingulate Inc. Common Stock has 14 employees. Workforce size can provide additional context about the company's scale and operations.

What is Cingulate Inc. Common Stock EBITDA?

Cingulate Inc. Common Stock EBITDA is -5.61 M, and its EBITDA margin is 1 929.37%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Cingulate Inc. Common Stock stock?

You can buy Cingulate Inc. Common Stock (CING) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Cingulate Inc. Common Stock stock?

Investing in Cingulate Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CING chart and related analysis on metatrader.com as part of your research.

News